Glycomimetics Inc (GLYC) SEC Filing 8-K Material Event for the period ending Tuesday, February 21, 2023

Glycomimetics Inc

CIK: 1007019 Ticker: GLYC

View differences made from one to another to evaluate Glycomimetics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Glycomimetics Inc.


Assess how Glycomimetics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Glycomimetics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: GLYC
CIK: 1253689
Form Type: 8-K Corporate News
Accession Number: 0001558370-23-001631
Submitted to the SEC: Tue Feb 21 2023 4:00:26 PM EST
Accepted by the SEC: Tue Feb 21 2023
Period: Tuesday, February 21, 2023
Industry: Pharmaceutical Preparations
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: